Showing results (1-10 of 2,060) with videos related to

Sort By:
Pageof 206
Climacteric : the Journal of the International Menopause Society|December 23, 2014
Effects of an aglycone-rich biotransformed soybean extract in human endothelial cellsC M De Andrade, F J Bianchini, F M Rey, et al.
Climacteric : the Journal of the International Menopause Society|October 21, 2014
Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levelsR J Santen
Climacteric : the Journal of the International Menopause Society|November 25, 2014
Endothelial function in women of the Kronos Early Estrogen Prevention StudyJ M Kling, B A Lahr, K R Bailey, et al.
Climacteric : the Journal of the International Menopause Society|October 22, 2015
FRAX and fracture prediction without bone mineral densityJ A Kanis, N C Harvey, H Johansson, et al.
Climacteric : the Journal of the International Menopause Society|November 3, 2015
Muscle mass and insulin sensitivity in postmenopausal women after 6-month exercise trainingB K J Glouzon, R Barsalani, J-C Lagacé, et al.
Climacteric : the Journal of the International Menopause Society|June 22, 2016
Cardiovascular risk assessment in women - an updateP Collins, C M Webb, T J de Villiers, et al.
Climacteric : the Journal of the International Menopause Society|April 21, 2016
The American-European difference in vulvar and vaginal atrophy views: a lesson from the REVIVE SurveyR E Nappi, M L Krychman
Climacteric : the Journal of the International Menopause Society|February 14, 2016
2016 IMS Recommendations on women's midlife health and menopause hormone therapyR J Baber, N Panay, A Fenton, et al.
Climacteric : the Journal of the International Menopause Society|March 5, 2016
Evaluation of sexuality in a Paraguayan mid-aged female urban population using the six-item Female Sexual Function IndexS C Sánchez, P Chedraui, F R Pérez-López, et al.
Climacteric : the Journal of the International Menopause Society|March 28, 2013
One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal womenA R Genazzani, T Schmelter, M Schaefers, et al.
Pageof 206